Exploring Moringa as a Natural Approach to Osteoarthritis Management

Published on
November 15, 2026

Pharmacology, Progressive Education Society’s Modern College of Pharmacy, Nigdi- Pune, India

Areas of Expertise
Pharmacy, Pharmacology, Clinical pharmacy, Preclinical pharmacy

Osteoarthritis (OA) is often called wear and tear, but the phrase undersells it. It is a disease of the whole joint: cartilage erodes, the bone beneath it remodels, osteophytes form and the synovial lining becomes inflamed. Global Burden of Disease estimates suggest that more than 600 million people are affected worldwide. That complexity is exactly what makes treatment difficult. Mechanical load, ageing, metabolic factors and persistent low-grade inflammation all feed the same process, and no single drug target captures them all.

What clinics can offer today is largely symptomatic. Paracetamol, oral non-steroidal anti-inflammatory drugs (NSAIDs) and intra-articular corticosteroids can ease pain and stiffness, but none has convincingly halted cartilage loss. Prolonged NSAID use carries gastrointestinal and cardiovascular risks, which matter most in older patients who often live with other conditions. By the time a joint replacement is discussed, the window for protecting cartilage has usually closed. This gap between symptom relief and genuine disease modification is why researchers keep looking at new candidates, including plants with long histories of traditional use. The aim is not to replace established care but to find safer options that could sit alongside it or, ideally, slow the disease itself.

Moringa oleifera, known as the drumstick tree in English and shevga in Marathi, is familiar in Indian kitchens and village medicine alike. Leaves, flowers, seeds and pods are eaten, and preparations from the plant have been used traditionally for inflammatory complaints. Laboratory studies have reported antioxidants, anti-inflammatory and anti-arthritic activity, and several reports show that Moringa extracts can dampen NF-κB signaling, a central switch for inflammatory gene expression.

Yet most of this work has concentrated on leaves, flowers and seeds. The pod, which is widely consumed and easy to source, has received far less attention in the context of joint disease. Its low cost, wide availability and history as a food are attractive for a condition that is chronic, common and expensive to manage. That gap in literature was our starting point. We were also curious about whether a whole pod, hydroalcoholic extract, which is closer to how the plant is actually used than a purified compound, could show measurable effects on both symptoms and tissue structure.

Using phytochemical screening and high-performance thin-layer chromatography (HPTLC), we confirmed that our hydroalcoholic pod extract, which we abbreviate as HEMO, contains flavonoids and phenolic acids. The fingerprint identified quercetin, kaempferol, gallic acid and chlorogenic acid.

Each of these has a plausible role in the joint. Quercetin and kaempferol are flavonoids known to scavenge free radicals and to restrain pro-inflammatory signaling. Gallic acid and chlorogenic acid are phenolic acids with antioxidants and anti-inflammatory properties reported in other disease models. Together they could act on two fronts: neutralizing reactive oxygen species before they damage chondrocytes and reducing the cytokine signals that push cartilage cells toward breaking down their own matrix. I should stress that this is a reasoned interpretation. We identified the compounds but did not test each one individually, so we cannot say which contributes most or whether they act together. Flavonoids and phenolic acids are not always efficiently absorbed after oral dosing, which is one reason why pharmacokinetic work matters so much later on.

Cartilage is a quiet tissue with little blood supply and limited capacity to repair itself, so it is vulnerable when the surrounding environment turns hostile. In OA, cytokines such as interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α) prompt chondrocytes and synovial cells to produce matrix metalloproteinases, notably MMP-13, which cuts through type II collagen, the structural backbone of cartilage . Excess reactive oxygen species add to the damage by injuring chondrocytes directly and by amplifying the inflammatory signals.

This suggests a chain of events: oxidative stress and inflammation raise enzyme activity, enzyme activity degrades collagen, and collagen loss undermines the joint. Interrupting the chain at its early links, by supporting the body’s antioxidant enzymes and lowering cytokine levels, could in principle slow the destruction downstream. This is the logic behind looking at plant-derived compounds that act on several links at once. It also explains why markers of inflammation, oxidative balance and cartilage breakdown are worth measuring together rather than in isolation: each tells us about a different step in the same story.

We induced OA in female Wistar rats with intra-articular papain, an enzyme that degrades cartilage and produces an OA-like picture. Animals were divided into five groups of six: normal control, untreated disease control, a glucosamine sulphate reference group, and two HEMO groups at 100 and 200 mg/kg given orally for 28 days. In a separate acute toxicity test following OECD Guideline 423, HEMO was well tolerated up to 2000 mg/kg with no deaths or signs of toxicity over 14 days.

Untreated arthritic animals lost weight, developed swollen knees, became stiff and moved less. Treatment reversed these changes in a dose-dependent way. At 200 mg/kg, HEMO significantly reduced knee diameter and joint stiffness, improved locomotor activity and helped restore body weight. The 100 mg/kg dose gave smaller, though still measurable, improvements. Radiographs and histology told a consistent story: the untreated joints showed narrowing of the joint space, osteophytes, inflammatory cell infiltration and disturbed cartilage matrix, whereas treated joints, particularly at the higher dose, looked considerably better preserved. It is worth being candid about the limits here: each group had only six animals, all were female, and the treatment period was short. The pattern was consistent across many independent measures, which gives me some confidence, but it needs replication before it can be treated as settled.

The blood markers helped us understand why the joints looked better. In the disease control group, IL-1β averaged 61.8 and TNF-α 82.5 in the units reported, against 10.4 and 23.0 in normal animals. At 200 mg/kg, HEMO brought these down to 45.2 and 30.7. C-reactive protein and erythrocyte sedimentation rate, two general measures of inflammation, fell in parallel. Interestingly, the TNF-α value in the HEMO 200 mg/kg group was lower than in the glucosamine group, although glucosamine performed better on most other measures.

The antioxidant picture moved in the opposite direction. Superoxide dismutase and catalase, the enzymes that neutralize reactive oxygen species, were depressed by papain and recovered with treatment, with the higher dose again doing more. Alkaline phosphatase, which reflects bone turnover and joint injury, was lowered as well.

The change in MMP-13 is perhaps the most telling. It roughly doubled in diseased animals (10.35 against 4.72 in normal controls) and dropped to 5.93 with HEMO 200 mg/kg. Since MMP-13 is the enzyme that dismantles cartilage collagen, this suggests that the extract does more than relieve swelling: it appears to act on a step that determines whether cartilage survives. Taken together, lower cytokines, restored antioxidant defenses and reduced MMP-13 fit with the improved histology. That said, these are associations measured in serum. We did not measure NF-κB or other signaling molecules directly, so the mechanism remains a hypothesis to be tested rather than a conclusion.

The results are encouraging, but a rat study is a first step, not a recommendation. Several things need to happen before anyone should consider Moringa pod preparations for people with OA.

First, the extract must be standardized. Plant chemistry varies with cultivar, soil, harvest time and extraction method, and the literature already points to differences between wild and cultivated Moringa. A clinical product needs defined marker compounds, batch-to-batch consistency and quality control. Second, the safety work must go beyond a single acute test, to include repeated-dose and chronic toxicity studies, and an assessment of interactions with drugs commonly taken by OA patients, such as anticoagulants and antihypertensives. Third, pharmacokinetic studies are needed to learn which compounds are absorbed, at what levels, and whether they reach joint tissue.

On the science side, we should confirm efficacy in additional models, including surgically induced or mechanically driven OA, which may reflect human disease better than an enzyme-induced model, and in animals of both sexes and different ages. Mechanistic studies should test NF-κB and related pathways directly, and fractionation could identify the most active constituents. Our comparison with glucosamine sulfate is also worth handling carefully, since the clinical evidence for glucosamine itself is debated. Only after this groundwork would well-designed, adequately powered, randomized controlled trials be justified, with outcomes that matter to patients, such as pain, function and imaging changes over time. Until then, Moringa pods are best viewed as a promising lead in the search for gentler, disease-modifying options, and people living with OA should continue to follow the advice of their physicians. Pod extracts are not a substitute for prescribed treatment, and self-medicating with concentrated preparations is not something these data support.

References

Gavane VS, Gojare SA, Bandawane DD. Evaluation of anti-osteoarthritic activity of hydroalcoholic extract of Moringa oleifera by using papain-inducing model in experimental animals. Journal of Complementary and Integrative Medicine. 2026 Oct 8;23(3):403-12.
Article DOI

Saleem A, Saleem M, Akhtar MF. Antioxidant, anti-inflammatory and antiarthritic potential of Moringa oleifera Lam: An ethnomedicinal plant of Moringaceae family. South African Journal of Botany. 2020 Jan 1;128:246-56.
Article DOI

Chodur GM, Olson ME, Wade KL, Stephenson KK, Nouman W, Garima, Fahey JW. Wild and domesticated Moringa oleifera differ in taste, glucosinolate composition, and antioxidant potential, but not myrosinase activity or protein content. Scientific reports. 2018 May 22;8(1):7995.
Article DOI

Science Factors.

Awake Hand Surgery: Advancing Precision in Finger Tendon Repair

Dr. Madhusudhan NC
0
A finger injury may seem minor, but damage to its tendons can seriously affect hand movement. What role do tendons play in finger function,...

Tiny Pores, Big Possibilities: Toward Intelligent Nanodevices

Dr. Pramodt Srinivasula
0
What are nanopores, and why is controlling the movement of ions through these tiny channels important in science and technology? Nanopores are extremely tiny openings,...

When ‘Stay Positive’ Goes Too Far: The Hidden Psychology of Toxic Positivity

Dr Alphonsa Jose K
0
What exactly is “toxic positivity,” and how is it different from having a genuinely positive or hopeful outlook on life? Toxic positivity is different from...

Breathing on Their Own Again: A New Approach After Brain Injury

Dr. Sooraj Mavilakandy
0
Why is deciding when to remove a tracheostomy particularly challenging in patients recovering from brain injury, and what are the risks of removing it...

Helping Mothers Breastfeed with Confidence: What Hospitals Can Change

Dr. Inderdeep Singh Kochar
0
Why do some mothers stop breastfeeding early even when they understand its benefits? Picture a new mother on the postnatal ward. Her baby cries after...

Rare Hemoglobin Variants: Improving Diagnosis Through Integrated Laboratory Testing using Chromatography, Electrophoresis and Mass Spectrometry Techniques

Dr. Deepalakshmi PD
0
What are hemoglobin variants, and why is it important to correctly identify even rare variants that may not initially cause obvious symptoms? Hemoglobin is the...

A Clearer View of Acid Reflux: Improving Assessment During Endoscopy

Dr. Sabu K. G.
0
What causes acid reflux, and why is the barrier between the stomach and esophagus important? Gastroesophageal reflux disease (GERD) is one of the most common...

Natural Defenses in Meghalaya’s Traditional Potatoes Against the Tuber Moth Insect Pest

Dr. Kennedy Ningthoujam
0
Potato tuber moth is a destructive insect pest of potato crops. What makes this pest particularly challenging for potato growers, both in the field...